Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

OBJECTIVE: The effect of metformin on weight reduction in polycystic ovary syndrome (PCOS) is often unsatisfactory. In this study, we investigated the potential add-on effect of treatment with the glucagon-like peptide-1 receptor agonist liraglutide on weight loss in obese nondiabetic women with PCO...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensterle Sever, Mojca, Kocjan, Tomaz, Pfeifer, Marija, Kravos, Nika Aleksandra, Janez, Andrej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922503/
https://www.ncbi.nlm.nih.gov/pubmed/24362411
http://dx.doi.org/10.1530/EJE-13-0797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922503/
https://www.ncbi.nlm.nih.gov/pubmed/24362411
http://dx.doi.org/10.1530/EJE-13-0797

Ejemplares similares